Keyword: Food and Drug Administration (FDA)

News

J&J Settles Risperdal Lawsuit for $7.8 Million

20.05.2015 - US pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over the marketing of its antipsychotic drug Risperdal to doctors in the US state of...

Plant Construction & Process Technology

Quality and Efficiency in Pharma Manufacturing

07.05.2015 - An investment in process analytical technology (PAT) is not just a capital investment, but also an investment in human resources and a commitment to change fundamental processes...

News

Alexion Paying $8.4 Billion to Acquire Synageva

07.05.2015 - US-based Alexion Pharmaceuticals is paying $8.4 billion to acquire compatriot rare disease specialist Synageva BioPharma. The deal expected to close in mid-2015 has raised...

News

EU Approves Sales of Sanofi’s New Diabetes Drug

29.04.2015 - The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus...

Plant Construction & Process Technology

Chengdu Rongsheng Pharmaceutical Goes Digital with MES

28.04.2015 - The Rongsheng pharmaceutical production plant at Chengdu in China's Sichuan province has entered into the digital age. The contract signed in June 2011 between Chengdu Rongsheng...

News

Daiichi Sankyo Unloads Entire Stake in Sun Pharma

23.04.2015 - In a pre-negotiated share sale agreed a year ago, Japan's Daiichi Sankyo has unloaded its entire 8.9% stake in India's mammoth generics producer Sun Pharmaceutical Industries...

News

US Grants Priority Review for Shire’s Lifitegrast Dry Eye Treatment

10.04.2015 - The US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) from Shire for its lifitegrast dry eye treatment for adults and has designated it as a Priority...

Plant Construction & Process Technology

Quality and Efficiency in Pharma Manufacturing

23.03.2015 - The pharmaceutical industry is confronting a variety of new and complex challenges in the face of globalization and changing market dynamics. The past decade has witnessed a...